BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 21242957)

  • 1. Vhl is required for normal pancreatic β cell function and the maintenance of β cell mass with age in mice.
    Choi D; Cai EP; Schroer SA; Wang L; Woo M
    Lab Invest; 2011 Apr; 91(4):527-38. PubMed ID: 21242957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of the von Hippel-Lindau gene in pancreatic beta cells impairs glucose homeostasis in mice.
    Cantley J; Selman C; Shukla D; Abramov AY; Forstreuter F; Esteban MA; Claret M; Lingard SJ; Clements M; Harten SK; Asare-Anane H; Batterham RL; Herrera PL; Persaud SJ; Duchen MR; Maxwell PH; Withers DJ
    J Clin Invest; 2009 Jan; 119(1):125-35. PubMed ID: 19065050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elimination of von Hippel-Lindau function perturbs pancreas endocrine homeostasis in mice.
    Puri S; García-Núñez A; Hebrok M; Cano DA
    PLoS One; 2013; 8(8):e72213. PubMed ID: 23977255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of HIF-2α in pancreatic β cells does not alter glucose homeostasis.
    Brunt JJ; Shi SY; Schroer SA; Sivasubramaniyam T; Cai EP; Woo M
    Islets; 2014; 6(5-6):e1006075. PubMed ID: 25833250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A role for von Hippel-Lindau protein in pancreatic beta-cell function.
    Puri S; Cano DA; Hebrok M
    Diabetes; 2009 Feb; 58(2):433-41. PubMed ID: 19033400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
    Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
    Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. von Hippel Lindau tumor suppressor regulates hepatic glucose metabolism by controlling expression of glucose transporter 2 and glucose 6-phosphatase.
    Park SK; Haase VH; Johnson RS
    Int J Oncol; 2007 Feb; 30(2):341-8. PubMed ID: 17203215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship of erythropoietin overexpression with von Hippel-Lindau tumour suppressor gene mutations between hypoxia-inducible factor-1α and -2α in sporadic clear cell renal carcinoma.
    Gong K; Zhang N; Zhang K; Na Y
    Int J Mol Med; 2010 Dec; 26(6):907-12. PubMed ID: 21042786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of the arylhydrocarbon receptor nuclear translocator (Arnt) suppresses von Hippel-Lindau disease-associated vascular tumors in mice.
    Rankin EB; Higgins DF; Walisser JA; Johnson RS; Bradfield CA; Haase VH
    Mol Cell Biol; 2005 Apr; 25(8):3163-72. PubMed ID: 15798202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hypoxia response pathway and β-cell function.
    Cantley J; Grey ST; Maxwell PH; Withers DJ
    Diabetes Obes Metab; 2010 Oct; 12 Suppl 2():159-67. PubMed ID: 21029313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Action of hypoxia-inducible factor in liver and kidney from mice with Pax8-rtTA-based deletion of von Hippel-Lindau protein.
    Mathia S; Paliege A; Koesters R; Peters H; Neumayer HH; Bachmann S; Rosenberger C
    Acta Physiol (Oxf); 2013 Mar; 207(3):565-76. PubMed ID: 23384425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EAF2 loss enhances angiogenic effects of Von Hippel-Lindau heterozygosity on the murine liver and prostate.
    Pascal LE; Ai J; Rigatti LH; Lipton AK; Xiao W; Gnarra JR; Wang Z
    Angiogenesis; 2011 Sep; 14(3):331-43. PubMed ID: 21638067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway.
    Carroll VA; Ashcroft M
    Cancer Res; 2006 Jun; 66(12):6264-70. PubMed ID: 16778202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute Vhl gene inactivation induces cardiac HIF-dependent erythropoietin gene expression.
    Miró-Murillo M; Elorza A; Soro-Arnáiz I; Albacete-Albacete L; Ordoñez A; Balsa E; Vara-Vega A; Vázquez S; Fuertes E; Fernández-Criado C; Landázuri MO; Aragonés J
    PLoS One; 2011; 6(7):e22589. PubMed ID: 21811636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic, but not myeloid-cell, expression of interleukin-1alpha is required for maintenance of insulin secretion and whole body glucose homeostasis.
    Collier JJ; Batdorf HM; Martin TM; Rohli KE; Burk DH; Lu D; Cooley CR; Karlstad MD; Jackson JW; Sparer TE; Zhang J; Mynatt RL; Burke SJ
    Mol Metab; 2021 Feb; 44():101140. PubMed ID: 33285301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic endocrine microadenomatosis in patients with von Hippel-Lindau disease: characterization by VHL/HIF pathway proteins expression.
    Périgny M; Hammel P; Corcos O; Larochelle O; Giraud S; Richard S; Sauvanet A; Belghiti J; Ruszniewski P; Bedossa P; Couvelard A
    Am J Surg Pathol; 2009 May; 33(5):739-48. PubMed ID: 19238077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of von Hippel-Lindau protein converts renin-producing cells into erythropoietin-producing cells.
    Kurt B; Paliege A; Willam C; Schwarzensteiner I; Schucht K; Neymeyer H; Sequeira-Lopez ML; Bachmann S; Gomez RA; Eckardt KU; Kurtz A
    J Am Soc Nephrol; 2013 Feb; 24(3):433-44. PubMed ID: 23393316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrogen sulfide inhibits hypoxia- but not anoxia-induced hypoxia-inducible factor 1 activation in a von hippel-lindau- and mitochondria-dependent manner.
    Kai S; Tanaka T; Daijo H; Harada H; Kishimoto S; Suzuki K; Takabuchi S; Takenaga K; Fukuda K; Hirota K
    Antioxid Redox Signal; 2012 Feb; 16(3):203-16. PubMed ID: 22004513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PVHL is a regulator of glucose metabolism and insulin secretion in pancreatic beta cells.
    Zehetner J; Danzer C; Collins S; Eckhardt K; Gerber PA; Ballschmieter P; Galvanovskis J; Shimomura K; Ashcroft FM; Thorens B; Rorsman P; Krek W
    Genes Dev; 2008 Nov; 22(22):3135-46. PubMed ID: 19056893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The zinc transporter Slc39a5 controls glucose sensing and insulin secretion in pancreatic β-cells via Sirt1- and Pgc-1α-mediated regulation of Glut2.
    Wang X; Gao H; Wu W; Xie E; Yu Y; He X; Li J; Zheng W; Wang X; Cao X; Meng Z; Chen L; Min J; Wang F
    Protein Cell; 2019 Jun; 10(6):436-449. PubMed ID: 30324491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.